Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.00%
)
US TECH 100
29,057.60
(
1.24%
)
Dow Jones
50,579.70
(
0.00%
)
Brent Oil
96.18
(
-4.93%
)
Bitcoin
77,003.99
(
-0.35%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 12
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: oc631 post# 171461

Wednesday, 12/18/2013 10:34:51 AM

Wednesday, December 18, 2013 10:34:51 AM

Post# of 257628

The bearish argument against ABBV is that with these results they do not have a credible "natural" positioning strategy in the market



I will not sell Abbott short regarding to marketing. Abbott has an outstanding marketing expertise and capabilities. With all these numbers coming from HCV trials, the marketing will be the key.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today